Dapagliflozin
Dapagliflozin
Dapagliflozin (pronounced da-pa-gli-flo-zin) is a medication used to treat Type 2 diabetes and heart failure. It is classified under the drug class known as sodium-glucose co-transporter 2 (SGLT2) inhibitors.
Etymology
The name "Dapagliflozin" is derived from its chemical structure. "Dapa" is short for dihydropyran, a chemical group present in the molecule, "gli" refers to glucose, and "flozin" is a common suffix for drugs in the SGLT2 inhibitor class.
Usage
Dapagliflozin works by helping the kidneys get rid of glucose from your bloodstream. It is used in combination with diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is also used to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.
Related Terms
- Type 2 diabetes: A chronic condition that affects the way the body processes blood sugar (glucose).
- Heart failure: A condition in which the heart can't pump enough blood to meet the body's needs.
- Sodium-glucose co-transporter 2 (SGLT2) inhibitors: A class of prescription medicines that are FDA-approved for use with diet and exercise to lower blood sugar in adults with type 2 diabetes.
External links
- Medical encyclopedia article on Dapagliflozin
- Wikipedia's article - Dapagliflozin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski